Nutriband Inc (NTRB : NASDAQ)
Common Stock
$8.99
USD
+1.64 (22.31%)
Last updated: 2026-09-24
Follow NTRB
NTRB
Nutriband Inc
WealthAwesomePerformance
1 Day
+22.31%
1 Week
+17.52%
1 Month
+86.13%
YTD
+193.79%
Key Statistics
Market Cap
$109.28M
52W High
$9.00
52W Low
$2.80
P/E Ratio
-
50 Day MA
$4.40
200 Day MA
$4.09
Beta
2.04
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $7.35 | $9.00 | $7.35 | $8.99 | $8.99 | 387,875 |
| 9/23/2026 | $6.75 | $7.50 | $6.56 | $7.35 | $7.35 | 129,731 |
| 9/22/2026 | $7.78 | $7.88 | $6.66 | $6.76 | $6.76 | 319,603 |
| 9/21/2026 | $8.21 | $8.55 | $7.30 | $7.77 | $7.77 | 135,104 |
| 9/18/2026 | $7.66 | $8.13 | $7.03 | $8.13 | $8.13 | 110,513 |
| 9/17/2026 | $7.11 | $7.66 | $6.94 | $7.65 | $7.65 | 102,847 |
| 9/16/2026 | $6.87 | $7.05 | $6.69 | $7.04 | $7.04 | 44,731 |
| 9/15/2026 | $6.85 | $7.05 | $6.72 | $6.82 | $6.82 | 45,558 |
| 9/14/2026 | $6.92 | $7.04 | $6.52 | $6.92 | $6.92 | 108,626 |
| 9/11/2026 | $6.18 | $6.97 | $6.09 | $6.96 | $6.96 | 99,826 |
Analyst Price Targets
Based on 1 analyst covering NTRB · as of Sep 17, 2026
Wall Street analysts forecast NTRB stock price to rise 66.9% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$15.00
+66.9% Upside
Current Price
US$8.99
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NTRB's historical volatility
30-Day Vol
125.4%
Annualized
90-Day Vol
93.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$10.75
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$9.54 | US$6.19 – US$14.71 |
| 60 trading days | US$10.13 | US$5.49 – US$18.67 |
| 90 trading days | US$10.75 | US$5.08 – US$22.74 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Financials
- Revenue (TTM)
- $1.62M
- EBITDA
- $-6.90M
- Profit Margin
- 0.00%
- ROE (TTM)
- -100.75%
- EPS (Diluted)
- -0.60
- Book Value
- 0.44
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About NTRB.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |